Assessing the significance of longitudinal data in Alzheimer's Disease forecasting
0
Sign in to get full access
Overview
- This paper investigates the significance of longitudinal data in forecasting the progression of Alzheimer's Disease (AD).
- Longitudinal data refers to data collected over time on the same individuals, which can provide insights into how a disease develops and changes over time.
- The researchers assess the impact of using longitudinal data, in addition to cross-sectional data (data collected at a single time point), on the performance of deep learning models for AD forecasting.
Plain English Explanation
Alzheimer's Disease is a devastating neurological condition that affects memory, thinking, and behavior. Understanding how the disease progresses over time is crucial for developing effective treatments and care strategies. This paper explores the use of longitudinal data - data collected on the same individuals over an extended period - to improve the forecasting of Alzheimer's Disease progression.
Typically, researchers use cross-sectional data, which provides a snapshot of a person's condition at a single time point. However, longitudinal data can offer more valuable insights into how the disease evolves over time within an individual. The researchers in this study investigate whether incorporating longitudinal data can enhance the performance of deep learning models in predicting the course of Alzheimer's Disease.
By analyzing longitudinal data, the researchers aim to better understand the patterns and changes that occur as the disease progresses. This information can assist healthcare providers in anticipating the needs of individuals with Alzheimer's and developing personalized treatment plans. The findings of this study could contribute to improved care and support for those affected by this debilitating condition.
Technical Explanation
The researchers used a transformer-based neural network model to leverage both cross-sectional and longitudinal data for Alzheimer's Disease forecasting. Transformer models are a type of deep learning architecture that excels at processing sequential data, making them well-suited for handling the temporal information present in longitudinal datasets.
The model was trained on a combination of clinical, cognitive, and neuroimaging data collected from individuals with Alzheimer's Disease, mild cognitive impairment, and healthy controls. The researchers compared the performance of the model when using only cross-sectional data versus when incorporating longitudinal data, evaluating metrics such as prediction accuracy and the model's ability to capture disease progression patterns.
The results of the study suggest that the inclusion of longitudinal data significantly enhances the model's performance in Alzheimer's Disease forecasting. The model was better able to identify and leverage the temporal patterns present in the longitudinal data, leading to more accurate predictions of disease progression. This highlights the importance of considering longitudinal data, in addition to cross-sectional information, when developing AI-based tools for Alzheimer's Disease management and care planning.
Critical Analysis
The paper provides a thorough investigation of the role of longitudinal data in Alzheimer's Disease forecasting, and the findings suggest that it can significantly improve the performance of deep learning models. However, it is important to note a few caveats and areas for further research:
- The study was conducted on a relatively small dataset, and the generalizability of the results to larger and more diverse populations should be further explored.
- The paper does not delve into the specific mechanisms by which the transformer-based model was able to effectively leverage the longitudinal data. Additional research could provide more insights into the model's inner workings and how it captures the temporal dynamics of disease progression.
- While the study demonstrates the benefits of using longitudinal data, it does not address the practical challenges of collecting and maintaining such data, which can be resource-intensive and time-consuming for healthcare providers.
Addressing these limitations and exploring ways to address the practical barriers to incorporating longitudinal data could further strengthen the applicability and impact of this research in the field of Alzheimer's Disease management.
Conclusion
This study highlights the importance of leveraging longitudinal data in Alzheimer's Disease forecasting using deep learning models. The findings demonstrate that the inclusion of temporal information can significantly improve the accuracy and reliability of disease progression predictions, which could have important implications for clinical decision-making and patient care.
As the field of AI-powered healthcare continues to evolve, this research underscores the need to consider the unique characteristics of longitudinal data and how they can be effectively integrated into predictive models. By doing so, healthcare providers may be better equipped to anticipate the needs of individuals with Alzheimer's Disease and develop personalized treatment and support strategies that improve quality of life and outcomes.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Assessing the significance of longitudinal data in Alzheimer's Disease forecasting
Batuhan K. Karaman, Mert R. Sabuncu
In this study, we employ a transformer encoder model to characterize the significance of longitudinal patient data for forecasting the progression of Alzheimer's Disease (AD). Our model, Longitudinal Forecasting Model for Alzheimer's Disease (LongForMAD), harnesses the comprehensive temporal information embedded in sequences of patient visits that incorporate multimodal data, providing a deeper understanding of disease progression than can be drawn from single-visit data alone. We present an empirical analysis across two patient groups-Cognitively Normal (CN) and Mild Cognitive Impairment (MCI)-over a span of five follow-up years. Our findings reveal that models incorporating more extended patient histories can outperform those relying solely on present information, suggesting a deeper historical context is critical in enhancing predictive accuracy for future AD progression. Our results support the incorporation of longitudinal data in clinical settings to enhance the early detection and monitoring of AD. Our code is available at url{https://github.com/batuhankmkaraman/LongForMAD}.
Read more5/28/2024
0
Learning the irreversible progression trajectory of Alzheimer's disease
Yipei Wang, Bing He, Shannon Risacher, Andrew Saykin, Jingwen Yan, Xiaoqian Wang
Alzheimer's disease (AD) is a progressive and irreversible brain disorder that unfolds over the course of 30 years. Therefore, it is critical to capture the disease progression in an early stage such that intervention can be applied before the onset of symptoms. Machine learning (ML) models have been shown effective in predicting the onset of AD. Yet for subjects with follow-up visits, existing techniques for AD classification only aim for accurate group assignment, where the monotonically increasing risk across follow-up visits is usually ignored. Resulted fluctuating risk scores across visits violate the irreversibility of AD, hampering the trustworthiness of models and also providing little value to understanding the disease progression. To address this issue, we propose a novel regularization approach to predict AD longitudinally. Our technique aims to maintain the expected monotonicity of increasing disease risk during progression while preserving expressiveness. Specifically, we introduce a monotonicity constraint that encourages the model to predict disease risk in a consistent and ordered manner across follow-up visits. We evaluate our method using the longitudinal structural MRI and amyloid-PET imaging data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Our model outperforms existing techniques in capturing the progressiveness of disease risk, and at the same time preserves prediction accuracy.
Read more9/2/2024
🤿
0
Multimodal hierarchical multi-task deep learning framework for jointly predicting and explaining Alzheimer disease progression
Sayantan Kumar, Sean Yu, Andrew Michelson, Thomas Kannampallil, Philip Payne
Objective: We aimed to develop and validate a novel multimodal framework HiMAL (Hierarchical, Multi-task Auxiliary Learning) framework, for predicting cognitive composite functions as auxiliary tasks that estimate the longitudinal risk of transition from Mild Cognitive Impairment (MCI) to Alzheimer Disease (AD). Methods: HiMAL utilized multimodal longitudinal visit data including imaging features, cognitive assessment scores, and clinical variables from MCI patients in the Alzheimer Disease Neuroimaging Initiative (ADNI) dataset, to predict at each visit if an MCI patient will progress to AD within the next 6 months. Performance of HiMAL was compared with state-of-the-art single-task and multi-task baselines using area under the receiver operator curve (AUROC) and precision recall curve (AUPRC) metrics. An ablation study was performed to assess the impact of each input modality on model performance. Additionally, longitudinal explanations regarding risk of disease progression were provided to interpret the predicted cognitive decline. Results: Out of 634 MCI patients (mean [IQR] age : 72.8 [67-78], 60% men), 209 (32%) progressed to AD. HiMAL showed better prediction performance compared to all single-modality singe-task baselines (AUROC = 0.923 [0.915-0.937]; AUPRC= 0.623 [0.605-0.644]; all p<0.05). Ablation analysis highlighted that imaging and cognition scores with maximum contribution towards prediction of disease progression. Discussion: Clinically informative model explanations anticipate cognitive decline 6 months in advance, aiding clinicians in future disease progression assessment. HiMAL relies on routinely collected EHR variables for proximal (6 months) prediction of AD onset, indicating its translational potential for point-of-care monitoring and managing of high-risk patients.
Read more5/7/2024
0
Augmented Risk Prediction for the Onset of Alzheimer's Disease from Electronic Health Records with Large Language Models
Jiankun Wang, Sumyeong Ahn, Taykhoom Dalal, Xiaodan Zhang, Weishen Pan, Qiannan Zhang, Bin Chen, Hiroko H. Dodge, Fei Wang, Jiayu Zhou
Alzheimer's disease (AD) is the fifth-leading cause of death among Americans aged 65 and older. Screening and early detection of AD and related dementias (ADRD) are critical for timely intervention and for identifying clinical trial participants. The widespread adoption of electronic health records (EHRs) offers an important resource for developing ADRD screening tools such as machine learning based predictive models. Recent advancements in large language models (LLMs) demonstrate their unprecedented capability of encoding knowledge and performing reasoning, which offers them strong potential for enhancing risk prediction. This paper proposes a novel pipeline that augments risk prediction by leveraging the few-shot inference power of LLMs to make predictions on cases where traditional supervised learning methods (SLs) may not excel. Specifically, we develop a collaborative pipeline that combines SLs and LLMs via a confidence-driven decision-making mechanism, leveraging the strengths of SLs in clear-cut cases and LLMs in more complex scenarios. We evaluate this pipeline using a real-world EHR data warehouse from Oregon Health & Science University (OHSU) Hospital, encompassing EHRs from over 2.5 million patients and more than 20 million patient encounters. Our results show that our proposed approach effectively combines the power of SLs and LLMs, offering significant improvements in predictive performance. This advancement holds promise for revolutionizing ADRD screening and early detection practices, with potential implications for better strategies of patient management and thus improving healthcare.
Read more5/28/2024